Amgen

ASCO: Amgen's KRAS drug shows 'modest' efficacy beyond NSCLC

12 days ago   |   Fierce Biotech

Amgen's KRAS inhibitor has shown limited efficacy in early testing in patients with cancers outside of the lung. The study linked the high dose of AMG-510 to a response rate of...
Read more ...

BCMA Delay: FDA Refuses Review of Bristol Drug, Asks for More Info

BCMA Delay: FDA Refuses Review of Bristol Drug, Asks for More Info

13 days ago   |   Xconomy

Bristol Myers Squibb's bid to win FDA approval for its multiple myeloma cell therapy has hit a detour. The FDA declined to review the experimental treatment and has instead...
Read more ...

QurAlis Hauls In $42M to Move New ALS Therapies Into Human Testing

QurAlis Hauls In $42M to Move New ALS Therapies Into Human Testing

13 days ago   |   Xconomy   |   2 articles

Few drugs exist that treat amyotrophic lateral sclerosis, a progressive disease that kills the nerve cells that allow patients to initiate and control muscle movement. QurAlis...
Read more ...

Amgen: Senior Oncology Specialist - San Diego, CA

1 month ago   |   San Diego Biotechnology   |   4 articles

Amgen: No relocation assistance provided for this position.Territory: L10408Amgen Oncology is committed to helping patients take on some of the toughest canc San Diego, CA, US ...
Read more ...

Laura Shawver on why she came back after an $88M windfall; MorphoSys taps Amgen vet as CCO

1 month ago   |   San Diego Biotechnology

Laura Shawver Laura Shawver didn't quite understand cancer until she had it. By that point, in 2006, she had already been making oncology drugs for over 15 years, a...
Read more ...

Bio Roundup: Alnylam's Billions, COVID-19 Vaccines, Moma Debuts & More

Bio Roundup: Alnylam's Billions, COVID-19 Vaccines, Moma Debuts & More

1 month ago   |   Xconomy

The public markets are moving erratically, but Alnylam Pharmaceuticals showed this week that selling equity isn't the only way for biotech companies to raise cash. Late last...
Read more ...

Akero Heads to Top of Class in NASH; Genfit Says Pandemic Won't Delay Data

Akero Heads to Top of Class in NASH; Genfit Says Pandemic Won't Delay Data

1 month ago   |   Xconomy

Akero's FGF21 analog yields 63 percent to 72 percent relative hepatic fat reduction in Phase 2a study; the company awaits biopsy data hoping to see a fibrotic benefit. Also...
Read more ...

Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma's Path & More

Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma's Path & More

1 month ago   |   Xconomy

The coronavirus pandemic has shaken the global economy, but three life sciences venture capital firms this week announced new funds totaling nearly $3 billion. ARCH Venture...
Read more ...

Amgen teams up with Adaptive to both treat and prevent COVID-19

1 month ago   |   Fierce Biotech

After The Wall Street Journal first broke the news this week, Amgen and new partner Adaptive Biotechnologies have confirmed they are the latest pharma-biotech duo joining...
Read more ...

Amgen sees no 'significant delays' from pandemic to novel KRAS cancer drug

1 month ago   |   Fierce Biotech   |   2 articles

Amgen has become the latest biopharma to try to figure out the hit it may take to its pipeline timings amid the COVID-19 pandemic.
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Merck Outlines COVID-19 Ambitions With Buyout Deal, Collaborations

Merck Outlines COVID-19 Ambitions With Buyout Deal, Collaborations

Merck exited the holiday weekend with some fireworks of its own, announcing three major programs on Tuesday all related to investments in finding ways to treat and prevent... Read more ...

Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development

Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development

A stem cell biologist, a gene editing expert, and a data engineer walk into a room...and that's just a few of the people Daphne Koller has recruited in the past two years to... Read more ...

Site of LUX-ZEPLIN Dark Matter Search Project Carefully Ramps Up Science Work

Site of LUX-ZEPLIN Dark Matter Search Project Carefully Ramps Up Science Work

A photomultiplier tube array that is part of the LUX-ZEPLIN experiment at the Sanford Underground Research Facility in Lead, South Dakota. The photomultiplier tubes are... Read more ...

Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments

Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments

Privately held biotech ViaCyte has banked $27 million, the majority an installment of cash from a tranched $80 million Series D financing round it closed in late 2018. The... Read more ...

COVID-19 Sparks New Opportunities for Digital Health Companies

COVID-19 Sparks New Opportunities for Digital Health Companies

Clinicians and regulators are rethinking how healthcare is provided amid precautions prompted by COVID-19. In-person physician visits don't fit within the physical distancing... Read more ...

Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create... Read more ...

How a protein can inhibit cancer development in mice

In a new study, researchers have discovered how the protein PP2A can inhibit tumor growth in mice. The protein turns off an enzyme that stimulates cell growth, thus inhibiting... Read more ...

Biotechnology: Metal collector made of bacteria

Bacteria, fungi and plants sometimes produce metal-binding substances that can be harnessed, for example for the extraction of raw materials, for their separation, for cleaning... Read more ...

Rejuvenated fibroblasts can recover the ability to contract

A recent study has shown that rejuvenated fibroblasts can recover their ability to self-contract. This encouraging discovery holds great potential for applications in... Read more ...

Directed protein evolution with CRISPR-Cas9

New area of application for gene scissors: Optimized proteins for biomedical research. Read more ...